Delivery Order SPE2DE21D7009-SPE2D626F03W1
- Not listed
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $1,867 fixed-price delivery order with economic price adjustment on September 9, 2025, for pain management medical devices. The contract is set to be completed by September 16, 2025, with performance taking place in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a $26,980 fixed-price delivery order with economic price adjustment for pain management medical devices by the Medical Supply Chain, a defense-related procurement entity. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 12, 2025, represents a child contract with no set-aside designation. Work will be performed at the contractor's facility in...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $26,980 delivery order on November 28, 2025, for pain management medical devices and services. The contract, which carries a fixed-price structure with economic price adjustment provisions, is scheduled for completion by December 5, 2025, and will be performed in Valencia, California. This delivery order was issued without a set-aside designation and is funded through the Defense Department's...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $31,771.22 fixed-price delivery order (Contract No. 4570331497) on December 15, 2025, for pain management medical devices and related services. The award carries an economic price adjustment clause and is scheduled for completion by December 29, 2025. This delivery order was issued under the company's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop Support...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $23,176.50 fixed-price delivery order with economic price adjustment for pain management medical devices on August 20, 2025, with an ultimate completion date of August 27, 2025. This non-set-aside delivery order is funded by the Medical Supply Chain, a defense-related procurement entity within the Department of Defense, and will be performed in Valencia, California. The award represents a task...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a $41,406.68 fixed-price delivery order with economic price adjustment for pain management medical devices and services. The award, issued on September 9, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation and will be performed in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,771.22 for pain management medical devices on November 28, 2025, under a Defense Logistics Agency Troop Support Medical contract. The delivery order, which is fixed-price with economic price adjustment provisions and carries an ultimate completion date of December 5, 2025, represents a task order against the company's larger indefinite delivery contract (SPE2DE)...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $1,838.13 for pain management medical devices under a fixed-price contract with economic price adjustment provisions. The award, issued on November 28, 2025, with an ultimate completion date of December 17, 2025, is funded by the Defense Logistics Agency's Medical Supply Chain division, a defense-related procurement entity supporting the Department of Defense. The...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a $1,867.00 fixed-price delivery order with economic price adjustment on November 28, 2025, for pain management medical devices and services. The contract, identified as PAIN MANAGEMENT (4570238376), is set to be completed by December 5, 2025, with performance occurring in Valencia, California. This delivery order was funded by the Medical Supply Chain, a defense-related procurement entity, and represents...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, received a $31,798.00 fixed-price delivery order with economic price adjustment for pain management medical devices, awarded December 31, 2025, with an ultimate completion date of March 2, 2026. This delivery order, issued without a small business set-aside, is funded by the Defense Logistics Agency's Medical Supply Chain division and will be performed at the contractor's Valencia, California facility. The...
- SPE2DE21D7009Indefinite Delivery Contract
- SPE2DE21D7009-SPE2D626F03W1Delivery Order
Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a $26,980 fixed-price delivery order with economic price adjustment on November 28, 2025, under contract 4570237140 for pain management medical devices and services. The order, with an ultimate completion date of December 5, 2025, represents work to be performed in Valencia, California, and is funded by the Defense Logistics Agency's Medical Supply Chain division. This delivery order is issued under the company's larger indefinite delivery contract (SPE2DE) valued at $83.1 million with the Defense Logistics Agency Troop Support Medical branch, which enables Boston Scientific Neuromodulation to supply comprehensive neuromodulation solutions including spinal cord stimulation systems, implantable pain pumps, and associated accessories to military and Veterans Affairs medical facilities nationwide. The award carries no set-aside designation. The delivery order supports the Defense Department's non-opioid pain management initiative by providing advanced neuromodulation technologies to service members and veterans managing chronic pain from traumatic injuries. Boston Scientific Neuromodulation's product portfolio includes proprietary systems such as RestoreSensor and Spectra WaveWriter spinal cord stimulators, along with training, data management, and technical support services. This award reflects the government's continued reliance on Boston Scientific's specialized expertise in pain management technologies and demonstrates the efficiency of the indefinite delivery contract vehicle in enabling rapid procurement of critical medical devices for the military healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.0k | 11/27/25 |